Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Brittany Nicole Weber, MD, PhD, Brigham and Women's Hospital, explains the growing role of cardio-rheumatology clinics.

The growing role of cardio-rheumatology clinics

Cardio-rheumatology clinics use a heart team-like approach to enhance care for patients with chronic conditions such as lupus, psoriasis and rheumatoid arthritis. "It's not just about cardiology," the director of one clinic explains. "We work closely with rheumatologists, dermatologists and even primary care physicians to provide comprehensive care."

Thumbnail

Lawyer: Court decision over website trackers has ‘zero impact on patient privacy’

The U.S. Department of Health and Human Services has opted not to appeal a federal court decision that partially repealed the agency’s ban on website trackers.

abortion law ban pregnancy dobbs

Planned Parenthood sues Missouri over Medicaid defunding

Despite abortions being effectively banned in the state, a law that passed in May banned Medicaid funds from going to any organization that provides abortions in any state.

Eiman Jahangir, MD, a cardiologist with Vanderbilt University Medical Center (VUMC), successfully traveled to space and back Thursday, Aug. 29, on a Blue Origin rocket. The entire flight lasted approximately nine minutes. Blue Origin is the aerospace company founded by Amazon’s Jeff Bezos in 2000.

Cardiologist blasts into space on Jeff Bezos-funded Blue Origin rocket

The nine-minute flight was a complete success. Prior Blue Origin space tourism missions have included everyone from Bezos himself to Star Trek actor William Shatner.

How can the world’s AI stakeholders work together toward the common goal of international scientific agreement on AI’s risks?

International experts formulate scientific approach to AI risk management

A lot of people from a lot of organizations in a lot of countries are working to coordinate oversight of AI’s risks. A budding project seeks to bring many of these minds together to advance the worthy goal of building global consensus with scientific rigor.

money cybersecurity ransomware health IT data breach hacker

McLaren recovering from ransomware attack, unclear about data security

McLaren said it will still take time to update patient records, as it has been manually charting during the weeks-long outage.

Eli Lilly Zepbound Vials

Eli Lilly releases cheaper, single-use vials of weight loss drug

The new vials of Zepbound are available exclusively through the Eli Lilly telehealth platform.

Insulet Corporation, a Massachusetts-based medical device company focused on diabetes technology, announced that its Omnipod 5 Automated Insulin Delivery System is now cleared by the U.S. Food and Drug Administration (FDA) to manage type 2 diabetes (T2D).

FDA clears first automated insulin pump for type 2 diabetes

Insulet's Omnipod 5 Automated Insulin Delivery System was already cleared to help patients manage type 1 diabetes. 

Displaying 233 - 240 of 8453

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.